Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: Effects on steroidogenesis and oncogenesis

January 2, 2004
101 (2) 621-626

Abstract

We describe a mechanism of gene regulation involving formation of a complex between PSF protein and mouse VL30 (mVL30) retrotransposon RNA. PSF represses transcription of the insulin-like growth factor 1 (IGF1)-inducible gene P450scc by binding to an insulin-like growth factor response element (IGFRE) motif in the gene. The complex with mVL30 RNA releases PSF, allowing transcription to proceed. Retrovirally mediated transmission of mVL30 RNA to human tumor cells induced several genes, including oncogenes, which also are induced by IGF1, and promoted metastasis. In mice, steroid synthesis is activated in steroidogenic cells by pituitary hormones, which concomitantly induce transcription of mVL30 RNA in the cells. We showed that steroid synthesis could also be activated in mouse steroidogenic adrenal cells by transfection with cDNA encoding either mVL30 RNA tracts that form a complex with PSF or a small interfering RNA (siRNA) that degrades PSF transcripts. These results suggest that mVL30 RNA regulates steroidogenesis, and possibly other physiological processes of mice, by complex formation with PSF. Retrotransposons such as mVL30 apparently evolved not only as “junk” DNA but also as transcriptionally active noncoding DNA that acquired physiological and pathological functions.

Continue Reading

Acknowledgments

We thank Dr. James Patton for providing the anti-PSF antibody, Dr. Randall Urban for providing an expression plasmid encoding the PSF protein, and Dr. Cecilia Guerrier-Takada for providing the plasmid pmU6(-315/1)pBSKAmp. The research reported here was supported in part by Program Project Grant HL29019 from the National Institutes of Health and by generous gifts from private donors.

References

1
French, N. S. & Norton, J. D. (1997) Biochim. Biophys. Acta 1352, 33–47.
2
Song, X., Wang, B., Bromberg, M., Hu, Z., Konigsberg, W. & Garen A. (2002) Proc. Natl. Acad. Sci. USA 99, 6269–6273.
3
Patton, J. G., Porro, E. B., Galceran, J., Tempst, P. & Nadal-Ginard, B. (1993) Genes Dev. 7, 393–406.
4
Peng, R., Dye, B. T., Perez, I., Barnard, D. C., Thompson, A. B. & Patton, J. G. (2002) RNA 8, 1334–1347.
5
Urban, R. J., Bodenburg, Y., Kurosky, A., Wood, T. G. & Gasic, S. (2000) Mol. Endocrinol. 14, 774–782.
6
Shav-Tal, Y. & Zipori, D. (2002) FEBS Lett. 531, 109–114.
7
Das, G., Henning, D., Wright, D. & Reddy, R. (1988) EMBO J. 7, 503–512.
8
Gou, D., Jin, N. & Liu, L. (2003) FEBS Lett. 548, 113–118.
9
Waterman, M. R., Mason, J. I. & Simpson, E. R. (1988) Prog. Clin. Biol. Res. 274, 543–555.
10
Stocco, D. M. & Clark, B. J. (1996) Endocr. Rev. 17, 221–244.
11
Yasumura, Y., Buonassisi, V. & Sato, G. (1966) Cancer Res. 26, 529–535.
12
Schiff, R., Itin, A. & Keshet, E. (1991) Genes Dev. 5, 521–532.
13
Bohm, S., Bakke, M., Nilsson, M., Zanger, U. M., Spyrou, G. & Lund, J. (1993) J. Biol. Chem. 268, 3952–3963.
14
Carlock, L., Vo, T., Lorincz, M., Walker, P. D., Bessert, D., Wisniewski, D. & Dunbar, J. C. (1996) Brain Res. Mol. Brain 42, 202–212.
15
Sertie, A. L., Sossi, V., Camargo, A. A., Zatz, M., Brahe, C. & Passos-Bueno, M. R. (2000) Hum. Mol. Genet. 9, 2051–2058.
16
Mozer, B. A. & Benzer, S. (1994) Development 120, 1049–1058.
17
Furstenberger, G. & Senn, H. J. (2002) Lancet Oncol. 3, 298–302.
18
Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S. & Boon, T. (1995) J. Exp. Med. 182, 689–698.
19
Stoesz, S. P., Friedl, A., Haag, J. D., Lindstrom, M. J., Clark, G. M. & Gould, M. N. (1998) Int. J. Cancer 79, 565–572.
20
Easty, D. J., Mitchell, P. J., Patel, K., Florenes, V. A., Spritz, R. A. & Bennett, D. C. (1997) Int. J. Cancer 71, 1061–1065.
21
Shav-Tal, Y., Cohen, M., Lapter, S., Dye, B., Patton, J. G., Vandekerckhove, J. & Zipori, D. (2001) Mol. Biol. Cell 12, 2328–2340.

Information & Authors

Information

Published in

Go to Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences
Vol. 101 | No. 2
January 13, 2004
PubMed: 14704271

Classifications

Submission history

Published online: January 2, 2004
Published in issue: January 13, 2004

Acknowledgments

We thank Dr. James Patton for providing the anti-PSF antibody, Dr. Randall Urban for providing an expression plasmid encoding the PSF protein, and Dr. Cecilia Guerrier-Takada for providing the plasmid pmU6(-315/1)pBSKAmp. The research reported here was supported in part by Program Project Grant HL29019 from the National Institutes of Health and by generous gifts from private donors.

Authors

Affiliations

Xu Song
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520
Aiwei Sui
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520
Alan Garen*
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520

Notes

*
To whom correspondence should be addressed at: Bass Center, Room 218, 266 Whitney Avenue, New Haven, CT 06520-8114. E-mail: [email protected].
Contributed by Alan Garen, November 25, 2003

Metrics & Citations

Metrics

Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation information is sourced from Crossref Cited-by service.


Citation statements

Altmetrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

Cited by

    Loading...

    View Options

    View options

    PDF format

    Download this article as a PDF file

    DOWNLOAD PDF

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Personal login Institutional Login

    Recommend to a librarian

    Recommend PNAS to a Librarian

    Purchase options

    Purchase this article to access the full text.

    Single Article Purchase

    Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: Effects on steroidogenesis and oncogenesis
    Proceedings of the National Academy of Sciences
    • Vol. 101
    • No. 2
    • pp. 415-693

    Media

    Figures

    Tables

    Other

    Share

    Share

    Share article link

    Share on social media